PHIO: Phio Pharmaceuticals Corp. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
3 open-market buys totaling $17K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 17 | PHIO | Phio Pharmaceuticals Corp. | Plott Ronald Todd | Director | 2026-09-29 | $5K | 14% | 2 insiders |
| 18 | PHIO | Phio Pharmaceuticals Corp. | Plott Ronald Todd | Director | 2026-09-28 | $5K | 16% | 2 insiders |
| 17 | PHIO | Phio Pharmaceuticals Corp. | Bradford Patricia A | Director | 2026-09-24 | $7K | 11% | 2 insiders |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.